Roberta (“Robbie”) Alton is the Vice President of Clinical Operations at OnKure, Inc. She has nearly two decades of global clinical development and operations experience across various therapeutic areas, focusing primarily on the oncology space. Prior to joining OnKure, Mrs. Alton most recently served as Head of Clinical Operations at Denovo Biopharma LLC, where she developed timelines and infrastructure needed to operationalize global clinical trials that led to successful preparation and completion of NDA submissions. Prior to Denovo, she served as the Senior Director of Clinical Operations and Project Management at Halozyme, Inc., where she oversaw the implementation of Phases 1 – 3 studies across North America, Europe, Asia Pacific and Latin America. Previously, Mrs. Alton held the role of Global Clinical Trial Manager at PRA Health Sciences Inc., where she built and managed a cohesive clinical team, managed vendors and monitored the quality of clinical deliverables. Mrs. Alton received her B.S. and Pharm. in Pharmacy and Biochemistry from the University of the State of Sao Paulo, Brazil.